Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

11158	Companies
246306	Keywords
174278	Articles
133001	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 09/24/2026 at 10:38, 18 days 6 hours ago

Heidelberg Pharma dévoile des données prometteuses pour le Pamlectabart Tismanitin

Heidelberg Pharma Myélome Multiple Données Cliniques Pamlectabart Tismanitin Étude De Phase IIa
BRIEF

published on 09/24/2026 at 10:38, 18 days 6 hours ago

Heidelberg Pharma Reveals Promising Data for Pamlectabart Tismanitin

Clinical Data Heidelberg Pharma Multiple Myeloma Pamlectabart Tismanitin Phase IIa Study
PRESS RELEASE

published on 09/24/2026 at 10:33, 18 days 6 hours ago

Heidelberg Pharma Presented New Clinical Data for Lead ATAC Candidate Pamlectabart Tismanitin at IMS Annual Meeting 2026
Heidelberg Pharma presents new clinical data for lead ATAC candidate Pamlectabart Tismanitin at IMS Annual Meeting 2026, establishing Recommended Phase 2 Dose at 175 µg/kg and demonstrating favorable safety and efficacy in multiple myeloma patients

Heidelberg Pharma Phase I/IIa Study ATAC Candidate Pamlectabart Tismanitin IMS Annual Meeting 2026
BRIEF

published on 09/07/2026 at 09:04, 1 month 5 days ago

Heidelberg Pharma dévoilera de nouvelles données sur un candidat pour le traitement du myélome.

Heidelberg Pharma Myélome Multiple Données Cliniques Conjugué Anticorps-médicament Pamlectabart Tismanitin
BRIEF

published on 09/07/2026 at 09:04, 1 month 5 days ago

Heidelberg Pharma to Unveil New Data on Myeloma Candidate

Clinical Data Heidelberg Pharma Multiple Myeloma Antibody-drug Conjugate Pamlectabart Tismanitin
PRESS RELEASE

published on 09/07/2026 at 08:59, 1 month 5 days ago

Heidelberg Pharma to Present New Clinical Data on Lead ATAC Candidate Pamlectabart Tismanitin at International Myeloma Society Annual Meeting 2026
Heidelberg Pharma to present new clinical data on lead ATAC candidate Pamlectabart Tismanitin at International Myeloma Society Annual Meeting 2026

Clinical Data Heidelberg Pharma ATAC Candidate International Myeloma Society Pamlectabart Tismanitin
BRIEF

published on 08/28/2026 at 11:00, 1 month 15 days ago

Heidelberg Pharma et Huadong Medicine renforcent leur collaboration en matière d'ADC

Conjugués Anticorps-médicament Heidelberg Pharma Médecine Huadong Technologie ATAC® Partenariat En Biotechnologie
BRIEF

published on 08/28/2026 at 11:00, 1 month 15 days ago

Heidelberg Pharma and Huadong Medicine Enhance ADC Collaboration

Heidelberg Pharma Antibody Drug Conjugates Biotech Partnership Huadong Medicine ATAC® Technology
PRESS RELEASE

published on 08/28/2026 at 10:55, 1 month 15 days ago

Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates
Heidelberg Pharma and Huadong Medicine sign new collaboration agreement to jointly develop Antibody Drug Conjugates, expanding pipeline with innovative products

Heidelberg Pharma ADC Technology Antibody Drug Conjugates Collaboration Agreement Huadong Medicine
BRIEF

published on 08/28/2026 at 10:53, 1 month 15 days ago

Heidelberg Pharma et Huadong Medicine étendent leur collaboration sur les conjugués anticorps-médicament (ADC)

Conjugués Anticorps-médicament Heidelberg Pharma Accord De Collaboration Développement Biopharmaceutique Médecine Huadong

Accesswire

Published on 10/12/2026 at 15:00, 2 hours 32 minutes ago

Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 4 hours 32 minutes ago

U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 12 hours ago

Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 15 hours ago

BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 2 days 15 hours ago

Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology

View all ACCESSWIRE

EQS Group

Published on 10/12/2026 at 16:59, 32 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/12/2026 at 16:55, 36 minutes ago

Afreximbank Barbados Country Brief spotlights market’s economic resilience and reform-driven path for growth
Published on 10/12/2026 at 16:49, 42 minutes ago

Holding(s) in Company
Published on 10/12/2026 at 15:42, 1 hour 49 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/12/2026 at 15:41, 1 hour 50 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

Les Echos

Published on 10/12/2026 at 15:47, 1 hour 44 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 30 septembre 2026
Published on 10/12/2026 at 15:47, 1 hour 44 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026
Published on 10/12/2026 at 15:12, 2 hours 19 minutes ago

Statement of transactions in own shares from October 5, 2026 to October 9, 2026
Published on 10/12/2026 at 15:12, 2 hours 19 minutes ago

Déclaration des transactions sur actions propres réalisées du 05/10/2026 au 09/10/2026
Published on 10/12/2026 at 14:15, 3 hours 16 minutes ago

Guillemot Corporation S.A. | Weekly report share buyback from October 5 to October 9, 2026

View all LES ECHOS COMFI WIRE